Posted on

cbd oil for tourettes

Cbd oil for tourettes

People with Tourette’s syndrome often experience additional neurobehavioral problems which happen simultaneously. Some of them include:

The increased potency of THC showed visible withdrawal symptoms [20] which include anger, irritability, depression, restlessness, headache, loss of appetite, insomnia and severe cravings for marijuana.

The article is checked by our editorial team, which includes registered dietitians and medical doctors with extensive, real-world clinical experience.

Comorbidities

The difference between pure CBD oil and medical marijuana is in its content. While CBD exists in its pure form, medical marijuana [4] contains two different chemical components, THC and CBD.

Getting high from marijuana is a natural concern for everyone who’s never tried using it, as well as what damage it could do to one’s lungs and brain. The FDA hasn’t approved marijuana as medicine, and the CDC [18] doesn’t consider it to be one as well.

Although Tourette syndrome tics can happen anytime, there are certain triggers that can make them worse. Excitement and anxiety are the usual suspects, as well as hearing or seeing someone sniff or cough which can make them do the same.

Types of Tics

The search for alternative solutions in treating many serious neurological disorders nowadays has led to some incredible findings. Using medical marijuana and/or CBD for treating Tourette’s syndrome is one of them, as the question of their efficacy comes into play.

Since it’s being inhaled, the potential of damaging the lungs and cardiovascular system exists, as well as the still-unknown long-term effects it may have on your brain. Another problem with medical marijuana stems from the fact that the ingredients in each plant can be different, causing uncertainty in what kind and how much of a chemical you’re actually getting.

Cbd oil for tourettes

Participants in the clinical trial at Wesley Medical Research will complete two six-week "crossover" periods of treatment with active drug or placebo, with both participants and investigators unaware of treatment status until the trial is complete.

The Lambert Initiative was established in 2015 following a $33.7m donation from Barry and Joy Lambert to the University of Sydney to conduct high quality research to discover, develop and optimise safe and effective use of cannabinoid therapeutics in medicine. Lambert Initiative is based at the Brain and Mind Centre at the University of Sydney.

Chris Wright is the first participant in the trial. Chris developed Tourette syndrome in childhood and despite medication, his condition has persisted. Some people with Tourette syndrome experience side-effects to existing therapies including fatigue and weight gain.

The trial drugs

Tourette syndrome trial participant Chris Wright (left) and Dr Philip Mosley of Wesley Medical Research in Brisbane.

Tourette syndrome is a neurological disorder that develops in childhood and is characterised by involuntary movements and vocalisations (known as tics), which may be painful, embarrassing and functionally impairing.

About the Lambert Initiative

In collaboration with the Lambert Initiative, Bod Australia Limited will be supplying the pharmaceutical grade cannabis extract to be used in the trial. The trial will examine the safety and efficacy of cannabinoids on tic frequency as well as the psychiatric and cognitive symptoms associated with Tourette syndrome.

Medicinal cannabis, developed to pharmaceutical standards, contains a mixture of cannabidiol (CBD) and tetrahydrocannabinol (THC) – two active ingredients derived from the cannabis plant.